Amplifying the Patient Journey cover art

Amplifying the Patient Journey

Amplifying the Patient Journey

By: Practical Neurology
Listen for free

The heart of clinical practice is the patient. In this series, we speak with both providers and patients about the clinical journey with a neurologic condition, and what recent advances mean for patients, their providers, and caregivers.2024 Bryn Mawr Communications LLC Biological Sciences Science
Episodes
  • Bill Nye on Ataxia, Family Risk, and the Search for Answers

    Bill Nye on Ataxia, Family Risk, and the Search for Answers
    Jun 29 2026
    In this episode, Bill Nye—science communicator, television presenter, and ataxia advocate—shares his experience growing up in a family affected by ataxia, discusses the challenges of individuals living with rare neurologic diseases, and reflects on how he has been impacted by the knowledge of his own risk. He is joined by Lauren Moore, PhD, Vice President of Research and Chief Scientific Officer of the National Ataxia Foundation, Golden Valley, MN, who discusses common barriers to diagnosis, clinical management strategies, educational resources for neurologists, and the evolving ataxia treatment landscape.
    Show More Show Less
    22 mins
  • The Power of Movement for Parkinson Disease

    The Power of Movement for Parkinson Disease
    May 8 2026
    Dr. Nina Mosier, MD, an Internal Medicine physician specializing in Geriatric Medicine, shares the journey of her father after his diagnosis with Parkinson Disease. She also discusses the importance of movement in these patients and describes Power for Parkinson's, the movement organization for she co-founded and serves as executive director.Resources: https://www.powerforparkinsons.org/https://www.youtube.com/@PowerforParkinsons
    Show More Show Less
    22 mins
  • Living with Spinal Muscular Atrophy: Genetic Testing, Therapy, and More

    Living with Spinal Muscular Atrophy: Genetic Testing, Therapy, and More
    Jan 30 2026
    Andrew Cherico, a student at the University of Central Florida, Orlando, FL, discusses his experience living with spinal muscular atrophy (SMA), the impacts of available treatments, and how the condition intersects with his passion for sports journalism. He is joined by John W. Day, MD, PhD, Professor of Neurology and Pediatrics, Director, Division of Neuromuscular Medicine at Stanford University School of Medicine, and Co-Director of Stanford’s Neuro IGNITE Center, Stanford, CA, who describes the importance of genetic testing, the landscape of available SMA treatments, and the significance of the newly approved one-time gene therapy Itvisma (onasemnogene abeparvovec-brve; Novartis, East Hanover, NJ).
    Show More Show Less
    36 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet